U.S. pharma huge copyright scrapped two experimental weight loss products very last year—a as soon as-every day capsule, lotiglipron, as a result of elevated liver enzymes in addition to a 2 times-everyday tablet, danuglipron, on account of potent side effects—but CEO Albert Bourla has explained the company is decided to “Participate in and a